Research Topics
Genomes and Genes | A F GazdarSummaryAffiliation: University of Texas Southwestern Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Application of a methylation gene panel by quantitative PCR for lung cancersNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Cancer Lett 247:56-71. 2007..Our preliminary data on the analysis of sputum DNA specimens from cancer patients further support these observations...
Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiationAmit K Das
Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2201 Inwood Road, NC 7 208, Mail Code 9187, Dallas, TX 75390, USA
Cancer Res 66:9601-8. 2006....
Cytoglobin, the newest member of the globin family, functions as a tumor suppressor geneNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Cancer Res 68:7448-56. 2008..Our data constitute the first direct functional evidence for CYGB, the newest member of the globin family, as a tumor suppressor gene...
MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsLiqin Du
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA
J Exp Clin Cancer Res 29:75. 2010..However, the role of miRNAs in the pathogenesis and diagnosis of small cell carcinoma (SCLC), the majority of which represent the most aggressive lung tumors, has not been investigated...
Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic studyMasaharu Nomura
Dept, of Surgery I, Tokyo Medical University, Tokyo, Japan
J Clin Bioinforma 1:23. 2011..abstract:..
A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERTNorimasa Miura
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine, Tottori University, Yonago, Tottori 683 8503, Japan
BMC Mol Biol 10:5. 2009....
Should we continue to use the term non-small-cell lung cancer?A F Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390 8593, USA
Ann Oncol 21:vii225-9. 2010..For the patient to obtain maximum benefit from the recent developments in therapeutics, a multidisciplinary approach is required with co-operation between oncologists, surgeons, radiologists and pathologists...
Inhibition of EGFR signaling: all mutations are not created equalAdi F Gazdar
Hamon Center for Therapeutic Oncology Research and in the Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
PLoS Med 2:e377. 2005
Lung cancer cell lines as tools for biomedical discovery and researchAdi F Gazdar
University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390 8593, USA
J Natl Cancer Inst 102:1310-21. 2010..However, major problems including misidentification or cell line contamination remain. Ongoing studies and new approaches are expected to reveal the full potential of the lung cancer cell line panel...
Rapid screening for EGFR mutations: pros and consAdi F Gazdar
University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Cancer J 12:17-8. 2006
Preneoplasia of lung cancerAdi F Gazdar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical School, Dallas, TX, USA
Cancer Biomark 9:385-96. 2010..A study of preinvasive lung cancer has yielded much valuable biologic information that impacts on clinical management...
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapyAdi F Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX, 75390 8593, USA
Cancer Metastasis Rev 29:37-48. 2010....
Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitorsA F Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Oncogene 28:S24-31. 2009..Various second-generation EGFR TKIs are currently being evaluated and may have the potential to overcome T790M-mediated resistance by virtue of their irreversible inhibition of the receptor TK domain...
Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?Adi F Gazdar
UT Southwestern Medical Center, Dallas, TX 75390 8593, USA
Lung Cancer 68:309-18. 2010..Finally the issue of cell line contamination must be addressed and safeguarded against. A full understanding of the advantages and shortcomings of cell lines is required for the investigator to derive the maximum benefit from their use...
Molecular targets for cancer therapy and preventionAdi F Gazdar
University of Texas Southwestern Medical Center, Dallas, TX 75390 8593, USA
Chest 125:97S-101S. 2004..These studies demonstrate that multiple, often overlapping, mechanisms of disruption are present in lung cancer cells, presenting a plethora of molecular targets...
Apoptosis and lung cancer: a reviewNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8593, USA
J Cell Biochem 88:885-98. 2003..The role of apoptosis regulation in lung cancer with major focus on the differential sensitivities of the major subtypes is reviewed...
Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40Adi F Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Clin Lung Cancer 5:177-81. 2003..The molecular changes caused by each of these major etiologic factors and their interrelationships are the focus of this review...
Environmental tobacco smoke, carcinogenesis, and angiogenesis: a double whammy?Adi F Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA
Cancer Cell 4:159-60. 2003..While a weak carcinogen, nicotine promotes carcinogenesis by a number of different mechanisms. The authors' findings provide further evidence of the harmful effects of ETS and indicate the desirability of reducing exposure to it...
Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?Adi F Gazdar
Hamon Centre for Therapeutic Oncology Research, University of Texas Southwestern Medical Centre, Dallas, TX 75390, USA
Trends Mol Med 10:481-6. 2004..Cancer cells with mutant EGFR genes might become physiologically dependent on the continued activity of the gene for the maintenance of their malignant phenotype; however, this might also be a target for therapy...
Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomasK O Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA
Cancer Res 61:4556-60. 2001..Our results demonstrate frequent aberrant methylation of CDH13 in breast and lung cancers accompanied by loss of gene expression, although expression may occasionally be lost by other mechanisms...
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomasA K Virmani
Hamon Center for Therapeutic Oncology Research, and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Clin Cancer Res 7:1998-2004. 2001..Our findings may be of biological and clinical importance...
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancerS Zochbauer-Muller
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Cancer Res 61:3581-5. 2001..Methylation of FHIT commences during lung cancer pathogenesis and may represent a marker for risk assessment...
Aberrant methylation and simian virus 40 tag sequences in malignant mesotheliomaS Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA
Cancer Res 61:5727-30. 2001..Our results demonstrate a relationship between SV40 and aberrant methylation in MMs...
Aberrant promoter methylation of multiple genes in non-small cell lung cancersS Zochbauer-Muller
Hamon Center for Therapeutic Oncology Research, The University of Texas, Southwestern Medical Center at Dallas, 75390 8593, USA
Cancer Res 61:249-55. 2001....
DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancersM Suzuki
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Bld NB, Room 8206, 6000 Harry Hines Blvd, Dallas, TX 75390, USA
Br J Cancer 93:1029-37. 2005..Our results provide strong evidence that these TGFbeta-related genes are frequently deregulated through aberrant methylation in many human malignancies...
DNA methylation profiles of lung tumorsS Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8563, USA
Mol Cancer Ther 1:61-7. 2001..We conclude that SCLC, carcinoids, squamous cell carcinomas, and adenocarcinomas of the lung have unique profiles of aberrant methylation. Our findings should help us understand differences in the pathogenetic mechanisms of lung cancers...
Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus typeC Y Muller
Department of Obstetrics and Gynecology, Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas 75235 9032, USA
J Natl Cancer Inst 90:433-9. 1998..We examined abnormalities in FHIT and its RNA transcripts in cervical cancer cell lines and tumors. We also investigated the relationship between loss of heterozygosity (LOH) in FHIT/FRA3B and the presence of oncogenic HPV types...
Aberrant methylation during cervical carcinogenesisA K Virmani
Hamon Center for Therapeutic Oncology Research, and Department of Pathology, University of Texas Southwestern Medical Center, Dallas 85930, USA
Clin Cancer Res 7:584-9. 2001....
Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patientsA L Smith
Simmons Cancer Center, University of Texas, Dallas, USA
Br J Cancer 73:203-9. 1996..Aneuploidy was not found in preinvasive lesions accompanying the five metastatic cases. Our findings provide strong support for the concept of field cancerisation...
DNA analysis at p53 locus in adenoid cystic carcinoma: comparison of molecular study and p53 immunostainingY Yamamoto
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, USA
Pathol Int 48:273-80. 1998..These findings indicate that abnormalities of the p53 gene are involved in carcinogenesis and/or progression of this tumor and, furthermore, suggest that molecular analyses of ACC may provide information of prognostic importance...
Aberrant methylation of SPARC in human lung cancersM Suzuki
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Br J Cancer 92:942-8. 2005..001). Our findings are of biological interest and potentially of clinical importance in human lung cancers...
DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostainingY Yamamoto
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, USA
Pathol Int 48:265-72. 1998..These findings indicate that p53 gene mutation is an early event and occurs frequently at an early stage of precancerous lesions and may be responsible for most cases of malignant transformation of PA...
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele lossA Maitra
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Am J Pathol 159:119-30. 2001....
Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusionsM Sakaguchi
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas 75235 8593, USA
Br J Cancer 79:416-22. 1999..Our method appears to be highly specific and increases the sensitivity of detection of malignant cells; it may be a useful adjunct to routine cytopathological examination...
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3BY Tomizawa
Hamon Center for Therapeutic Oncology Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Proc Natl Acad Sci U S A 98:13954-9. 2001..These results are consistent with SEMA3B functioning as a TSG, the expression of which is inactivated frequently in lung cancers by allele loss and promoter region methylation...
Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinomaN Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA
Hum Pathol 32:169-77. 2001..Our results suggest that there may be multiple putative tumor suppressor genes located on both arms of chromosome 4 whose inactivation are important early events in the pathogenesis of colorectal carcinoma...
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionD G Burbee
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center at Dallas, TX 75390 8593, USA
J Natl Cancer Inst 93:691-9. 2001..3 that frequently undergoes allele loss in lung and breast cancers. We explored the hypothesis that RASSF1 encodes a tumor suppressor gene for lung and breast cancers...
Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancerArvind Virmani
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA
Int J Cancer 106:198-204. 2003..Our results suggest that methylation of TMS1 may play a role in the pathogenesis of small cell and non small lung and breast cancers...
A translational view of the molecular pathogenesis of lung cancerMitsuo Sato
Hamon Center for Therapeutic Oncology Research Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
J Thorac Oncol 2:327-43. 2007..These advances highlight the translation of molecular discoveries on lung cancer pathogenesis from the laboratory to the clinic...
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cellsMitsuo Sato
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas 75390-8593, USA
Cancer Res 66:2116-28. 2006....
Primary mammary small-cell carcinoma: a molecular analysis of 2 casesM P Hoang
Division of Anatomic Pathology and Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA
Hum Pathol 32:753-7. 2001..Second, mammary small-cell carcinoma is clonally related to ductal carcinoma in situ and might represent an example of divergent differentiation occurring in a multipotential neoplastic stem cell...
Epigenetic down-regulation of death-associated protein kinase in lung cancersShinichi Toyooka
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Clin Cancer Res 9:3034-41. 2003....
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological featuresR Maruyama
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8593, USA
Cancer Res 61:8659-63. 2001..CDH1 methylation positive status was independently associated with poor survival in multivariate analyses. Our results suggest that the methylation profile may be a potential new biomarker of risk prediction in bladder cancer...
Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washingsA Maitra
Department of Pathology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Cancer 93:73-9. 2001..CONCLUSIONS: The use of in situ hybridization technique bypasses the need for stringent specimen processing and allows identification of the specific cell type that expresses telomerase. Cancer (Cancer Cytopathol)..
Characterization of paired tumor and non-tumor cell lines established from patients with breast cancerA F Gazdar
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235 8593, USA
Int J Cancer 78:766-74. 1998..Our panel of paired tumor and non-malignant cell lines should provide important new reagents for breast cancer research...
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor typesNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA
Int J Cancer 109:786-92. 2004..Our results demonstrate that DcR1 and DcR2 genes are frequently methylated in various tumor types, and that the role of decoy receptors in tumor pathogenesis needs to be re-evaluated...
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cellsMakoto Suzuki
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Cancer Res 64:3137-43. 2004..These results provide direct evidence that loss of DNMT1 expression abrogates tumor-associated promoter methylation and the resultant silencing of multiple genes implicated in the pathogenesis of human lung and breast cancer...
Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancerShinichi Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas TX 75390-8593, USA
Int J Cancer 103:153-60. 2003..Our findings demonstrate important smoke exposure, histologic type and geography-related differences in the methylation profiles of NSCLC tumors...
Differential inactivation of caspase-8 in lung cancersNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, Departments of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, Texas 75390 8593, USA
Cancer Biol Ther 1:65-9. 2002..CASP8 may function as a tumor suppressor gene in neuroendocrine lung tumors...
Lung cancer in never smokers--a different diseaseSophie Sun
Division of Haematology and Oncology and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Nat Rev Cancer 7:778-90. 2007..This Review summarizes our current knowledge of this unique and poorly understood disease...
Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell linesKenichi Harada
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, TX 75390, USA
Oncogene 21:4345-9. 2002..In five of six cell lines, restoration of RASSF1A mRNA was confirmed by RT-PCR. Our findings indicate that aberrant promoter methylation of RASSF1A may contribute to the pathogenesis of many different forms of pediatric tumors...
Microdissection and the study of cancer pathwaysA Maitra
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, USA
Curr Mol Med 1:153-62. 2001..Importantly, it is now possible to analyze many of the genetic changes that precede cancer, thereby identifying populations "at risk" for developing malignancies in the future...
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrierG E Tomlinson
Department of Pediatrics, and the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas 75235 8593, USA
Cancer Res 58:3237-42. 1998..This breast tumor-derived cell line may provide a useful model system for the study of familial breast cancer pathogenesis and for elucidating BRCA1 function and localization...
Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinomaUbaradka G Sathyanarayana
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 8593, USA
Clin Cancer Res 9:6389-94. 2003..In this study, we investigated the loss of expression of three LN5-encoding genes in breast cancer cell lines and elucidated the mechanism of silencing of the genes in breast cancer cell lines and tumors...
Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancerNoriaki Sunaga
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, 75390, USA
Cancer Res 64:4277-85. 2004..These results suggest different roles for CAV1 in SCLC, where CAV1 acts like a tumor suppressor gene, and NSCLC, where it appears required for survival and growth...
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infectionMakoto Suzuki
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Oncogene 24:1302-8. 2005..Our results demonstrate a relationship between SV40 and methylation of multiple genes in MM, indicating that the virus plays a role in the pathogenesis of MM...
Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersSabine Zochbauer-Muller
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Int J Cancer 107:612-6. 2003..Our findings suggest that detection of methylation should be investigated as an intermediate marker for lung cancer risk assessment and response to chemopreventive regimens...
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferationDi Cai
Division of Translational Research, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Cancer Res 70:6477-85. 2010..Taken together, these data suggest that SRC-3 may be an important oncogene and therapeutic target for lung cancer...
Epigenetic inactivation of laminin-5-encoding genes in lung cancersUbaradka G Sathyanarayana
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Clin Cancer Res 9:2665-72. 2003..CONCLUSIONS: Our results demonstrate frequent epigenetic inactivation of LN5-encoding genes in lung cancers, and these findings are of biological interest and are potentially of clinical importance...
Hierarchical clustering of lung cancer cell lines using DNA methylation markersArvind K Virmani
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9593, USA
Cancer Epidemiol Biomarkers Prev 11:291-7. 2002..Our results show that DNA methylation patterns differ between NSCLC and SCLC cell lines and suggest that these patterns could be developed into a powerful molecular marker to achieve accurate diagnosis of lung cancer...
Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell culturesShinichi Toyooka
Hamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Clin Cancer Res 8:2292-7. 2002..CONCLUSIONS: We found differential FEZ1 expression in NSCLC and SCLC cell lines, and the absent expression in 3 of 6 short-term cultures of NSCLC tumors. FEZ1 may be related to tumorigenesis of lung cancer...
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancersX L Xu
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Cancer Res 61:7943-9. 2001..Our results suggest that epigenetic or mutational inactivation of hSRBC may contribute to the pathogenesis of several types of human cancers, marking hSRBC as a candidate tumor suppressor gene...
hTR repressor-related gene on human chromosome 10p15.1N Miura
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8593, USA
Br J Cancer 85:1510-4. 2001..Our findings strongly suggest that 10p15.1 harbours a gene involved in repression of telomerase RNA component in human somatic cells and each putative repressor (on 3p and 10p) may act independently...
DNA methylation based biomarkers in non-invasive cancer screeningN Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
Curr Mol Med 10:123-32. 2010..Thus, we review recent findings on DNA methylation based cancer biomarkers with particular focus on these applicable to the clinical specimens obtained non-invasively from cancer patients...
Promoter hypermethylation profile of ovarian epithelial neoplasmsPrakash B Makarla
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Clin Cancer Res 11:5365-9. 2005..The profile of aberrant methylation suggests that an accumulation of events at specific genes may trigger malignant transformation of some benign cystadenomas and LMP tumors...
The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancerIkuo Sekine
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd, Dallas, TX 75390 8593, USA
Oncogene 24:2735-8. 2005..We conclude that abnormalities of BAF180 are not frequently involved in the pathogenesis of lung cancer...
Aberrant methylation of Reprimo in lung cancerMakoto Suzuki
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593, USA
Lung Cancer 47:309-14. 2005..These data indicate that Reprimo methylation is frequent in lung cancers and occurs independently of p53 status. Methylation of Reprimo may play a role in the pathogenesis of lung cancers...
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cellsShinichi Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, TX 75390, USA
Oncogene 21:4340-4. 2002..These data, together with our previous findings, support a causal relationship between SV40 infection, progressive RASSF1A methylation and its silencing, and the pathogenesis of mesothelioma...
Aberrant methylation of Reprimo in human malignanciesTakao Takahashi
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390 8593, USA
Int J Cancer 115:503-10. 2005..Aberrant methylation of Reprimo with loss of expression is a common event and may contribute to the pathogenesis of some types of human malignancy...
Molecular pathogenesis of lung cancer and potential translational applicationsJohn D Minna
Hamon Center for Therapeutic Oncology Research, Department of Internal Medicine, Unversity of Texas, Dallas 75390-8593, USA
Cancer J 8:S41-6. 2002..Finally, correcting even single genetic abnormalities can reverse the malignant phenotype...
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesDavid S Shames
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
PLoS Med 3:e486. 2006....
Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalizedDavid Padron
Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA
Cancer Res 67:7695-702. 2007..Thus, the mutations that altered signaling also decreased the interaction of EGFRs with the mechanisms responsible for endosomal sorting...
Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosisHittu Matta
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas Texas 75390-8593, USA
Cancer Biol Ther 1:652-60. 2002....
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell linesKenichi Harada
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas 75390, USA
Cancer Res 62:5897-901. 2002..Our results suggest that deregulation of the death receptor pathway to apoptosis is frequent in many types of pediatric tumors and their cell lines...
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell linesJeet Gandhi
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
PLoS ONE 4:e4576. 2009..Mutations of EGFR (mEGFR) and copy number gains (CNGs) of EGFR (gEGFR) and HER2 (gHER2) have been reported to predict for TKI response. Mutations in KRAS (mKRAS) are associated with primary resistance to TKIs...
Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological featuresUbaradka G Sathyanarayana
Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
Clin Cancer Res 9:6395-400. 2003..These findings are of biological interest and potentially of clinical importance...
Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell linesHong Chen
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
J Biol Chem 278:3121-30. 2003..We therefore conclude that epigenetic regulation plays a potential role in regulating hDAB2IP expression in PCa and that these results also provide a new therapeutic strategy for PCa patients...
Alterations in the mitochondrial displacement loop in lung cancersMakoto Suzuki
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas Texas 75390, USA
Clin Cancer Res 9:5636-41. 2003..In tumors PCT changes were only present when the corresponding nonmalignant lung demonstrated a variation from the most common repeat number of seven...
Sun exposure related methylation in malignant and non-malignant skin lesionsUbaradka G Sathyanarayana
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Boulevard, Dallas, Texas 75390 8593, USA
Cancer Lett 245:112-20. 2007..These differences were highly significant (P<0.0001). These findings suggest that methylation commences in UV exposed skin at a relatively early age and occurs in skin prior to the onset of recognizable preneoplastic changes...
Loss of heterozygosity in benign breast epithelium in relation to breast cancer riskDavid M Euhus
Department of Pathology, University of Texas Southwestern Medical Center at Dallas, 75390 9155, USA
J Natl Cancer Inst 94:858-60. 2002..Accurate individualized breast cancer risk assessment may be possible based on molecular analysis of breast epithelial cells obtained by random FNA...
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersHisayuki Shigematsu
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA
Int J Cancer 118:257-62. 2006..In addition, for optimal therapeutic approach a comprehensive understanding of the genes related to EGFR signaling pathway, including RAS/RAF/MAPK and PI3K-AKT pathways, are required...
Cancer. A bull's eye for targeted lung cancer therapyJohn D Minna
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Science 304:1458-61. 2004
Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell linesWei Zhang
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA
J Thorac Oncol 4:161-6. 2009..In this study, we examined the effects of the histone deacetylase inhibitor, romidepsin, in combination with erlotinib, in NSCLC cell lines and xenografts...
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancersMasaharu Nomura
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
PLoS Med 4:e125. 2007..The objective of this study was to examine distributions of these three polymorphisms and their relationships to each other and to EGFR gene mutations and allelic imbalance (AI) in non-small cell lung cancers...
Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assayNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Cancer Epidemiol Biomarkers Prev 17:995-1000. 2008..We further showed similar applications with multiple other malignancies. Our assay might have important implications in early detection and surveillance of multiple malignancies...
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancersHisayuki Shigematsu
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390 8593, USA
J Natl Cancer Inst 97:339-46. 2005..However, the role of such mutations in the pathogenesis of lung cancers is unclear...
Methods for detecting DNA methylation in tumors: from bench to bedsideDavid S Shames
The Hamon Center of Therapeutic Oncology Research and the Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX, USA
Cancer Lett 251:187-98. 2007..In this article, we review genome-wide and quantitative, high- resolution methods for methylation analysis that are used in the laboratory and clinic, and discuss their potential for use in a clinical setting...
The relationship between aberrant methylation and survival in non-small-cell lung cancersS Toyooka
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
Br J Cancer 91:771-4. 2004..While there was no relationship between the other genes and survival, p16(INK4a) methylation was significantly related to unfavourable prognosis in lung adenocarcinomas...
Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genesUbaradka G Sathyanarayana
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593, USA
Cancer Res 64:1425-30. 2004..Of particular interest, methylation frequencies of LAMA3 helped to distinguish invasive (72%) from noninvasive (12%) tumors. These results suggest that methylation of LN5 genes has potential clinical applications in bladder cancers...
Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinomaRiichiroh Maruyama
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Cancer 100:1472-7. 2004..The purpose of the current study was to determine the correlation between the aberrant promoter methylation of multiple genes and survival in patients with nonsmall cell lung carcinoma (NSCLC)...
Tumor suppressor genes in lung cancerArvind K Virmani
Hamon Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA
Methods Mol Biol 222:97-115. 2003
Evaluation of candidate methylation markers to detect cervical neoplasiaNarayan Shivapurkar
Hamon Center for Therapeutic Oncology Research, Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75930, USA
Gynecol Oncol 107:549-53. 2007..We used quantitative PCR assays to evaluate methylation in five candidate genes (TNFRSF10C, DAPK1, SOCS3, HS3ST2 and CDH1) previously demonstrated as methylated in cervical cancer...
Molecular pathogenesis of lung cancerSabine Zochbauer-Muller
Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas, 75390 8593, USA
Annu Rev Physiol 64:681-708. 2002..All these strategies should aid in reducing the number of newly diagnosed lung cancer cases and in increasing the survival and quality of life of patients with lung cancer...
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteinsRuben D Ramirez
Hamon Center for Therapeutic Oncology Research and Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Cancer Res 64:9027-34. 2004..These HBEC lines are a valuable new tool for studying of the pathogenesis of lung cancer...
DNA methylation profiles of lymphoid and hematopoietic malignanciesTakao Takahashi
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
Clin Cancer Res 10:2928-35. 2004..CONCLUSIONS: The three major forms of lymphoid/hematopoietic malignancies show overlapping but individual patterns of methylation...
Mutation analysis of the PTEN/MMAC1 gene in lung cancerE Forgacs
Hamon Center for Therapeutic Oncology Research, University of Texas, Southwestern Medical Center, Dallas 75235, USA
Oncogene 17:1557-65. 1998..5% nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers...
Aberrant DNA methylation in lung cancer: biological and clinical implicationsSabine Zochbauer-Muller
Clinical Division of Oncology, Department of Medicine I, University Hospital, Vienna, Austria
Oncologist 7:451-7. 2002....
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patientsXiming Tang
Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
Cancer Res 65:7568-72. 2005..Our findings indicate that mutation of the tyrosine kinase domain of EGFR is an early event in the pathogenesis of lung adenocarcinomas, and suggest EGFR mutations as an early detection marker and chemoprevention target...
Clonality of combined tumorsJiaoti Huang
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA
Arch Pathol Lab Med 126:437-41. 2002..However, in a minority of these tumors, different areas may be derived from different precursor cells...
DNA methylation in lung cancerShinichi Toyooka
N Engl J Med 358:2513; author reply 2514. 2008
Lung cancer preneoplasiaIgnacio I Wistuba
Department of Pathology, M D Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA
Annu Rev Pathol 1:331-48. 2006....
Research Grants
- Novel Reagents and New Biomarkers for Lung CancerAdi Gazdar; Fiscal Year: 2007..Our proposal will generate unique reagents useful for many studies, identify the sequential molecular changes during multistage pathogenesis and validate markers for early detection and risk assessment. ..
- UNIQUE TISSUE AND TUMOR PROCESSING FACILITYAdi Gazdar; Fiscal Year: 2003..A charge back fee system will recover some of the costs and will be used for future expansion of the Facility, which is anticipated to become self sustaining after five years. ..
